Article
TERT Promoter Mutations in Thyroid Cancer.
Hormones & cancer - 1 Jun 2016
Alzahrani Ali S, Alsaadi Rawan, Murugan Avaniyapuram Kannan, Sadiq Bakr Bin
Abstract excerpt
Two mutations (C228T and C250T) in the promoter region of the telomerase reverse transcriptase (TERT) have recently been described in different types of cancer including follicular cell-derived thyroid cancer (TC). In this paper, we reviewed the rates of these mutations in different types and subtypes of TC, their association with a number of clinical and histopathological features and outcome of TC, and their...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
